相关实验视频
Updated: Jan 17, 2026

07:59
Murine Full-thickness Skin Transplantation
Published on: January 2, 2017
21.1K
免疫抑制对皮肤状细胞癌结局的影响
Jason C Klein1, Kathryn T Shahwan2, Ursa Bezan Petric3
1Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Journal of the American Academy of Dermatology
|September 20, 2025
概括
免疫抑制增加了皮肤状细胞癌 (CSCC) 结果不佳的风险. 这项研究证实免疫抑制是不良事件的独立预测因素,包括CSCC患者的复发和死亡.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 免疫抑制与皮肤状细胞癌 (CSCC) 的风险和严重程度增加有关.
- 在CSCC结果中免疫抑制的独立预后价值是不确定的.
研究的目的:
- 确定免疫抑制是否独立预测CSCC患者的不良结果.
主要方法:
- 一项回顾性队列研究,汇集了来自12个国际中心的数据.
- 收集的数据包括人口统计,免疫抑制状态,瘤特征,治疗和结果.
- 使用单变量和多变量竞争风险分析,对器官移植和慢性淋巴细胞白血病队伍进行子组分析.
主要成果:
- 包括11,930名患者 (3994名免疫抑制患者).
- 免疫抑制患者表现出更高风险的瘤特征和更差的结果.
- 免疫抑制独立预测了局部复发,远程转移,疾病特异性死亡和主要的不良结果.
结论:
- 免疫抑制是CSCC中主要不良结果的独立风险因素.
- 这些发现支持将免疫抑制状态纳入CSCC风险预测模型 (诺米图) 中.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Immunodeficiency Diseases
2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.0K
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Clinical Applications of Epidermal Stem Cells
3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
Pulmonary Tuberculosis I
844
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
844
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

